Q4 2018 13F Holders as of 12/31/2018
-
Type / Class
-
Equity / American Depositary Shares, each representing 1 Ordinary Shares
-
Shares outstanding
-
100M
-
Number of holders
-
60
-
Total 13F shares, excl. options
-
11.5M
-
Shares change
-
-22.4K
-
Total reported value, excl. options
-
$191M
-
Value change
-
-$7.77M
-
Put/Call ratio
-
0
-
Number of buys
-
28
-
Number of sells
-
-44
-
Price
-
$16.65
Significant Holders of Cellectis S.A. - American Depositary Shares, each representing 1 Ordinary Shares (CLLS) as of Q4 2018
88 filings reported holding CLLS - Cellectis S.A. - American Depositary Shares, each representing 1 Ordinary Shares as of Q4 2018.
Cellectis S.A. - American Depositary Shares, each representing 1 Ordinary Shares (CLLS) has 60 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 11.5M shares
of 100M outstanding shares and own 11.41% of the company stock.
Largest 10 shareholders include FMR LLC (4.24M shares), Capital World Investors (875K shares), ARK Investment Management LLC (714K shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (600K shares), ARMISTICE CAPITAL, LLC (589K shares), BlackRock Inc. (492K shares), CREDIT SUISSE AG/ (460K shares), SPHERA FUNDS MANAGEMENT LTD. (448K shares), Point72 Asset Management, L.P. (400K shares), and MORGAN STANLEY (335K shares).
This table shows the top 60 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.